価格表

在庫・価格 : 2025年04月27日 20時16分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
SCF Receptor, Soluble, Human, ELISA Kit, Quantikine (96 well) <c-kit, ELISA Kit>
データシート※最新のデータシートでない場合があります
DSCR00 RSDアールアンドディー システムズ
R&D Systems, Inc.
1 kit 本製品は取扱中止になりました 追加

在庫・価格 : 2025年04月27日 20時16分 現在

SCF Receptor, Soluble, Human, ELISA Kit, Quantikine (96 well) <c-kit, ELISA Kit>

  • 商品コード:DSCR00
  • メーカー:RSD
  • 包装:1kit
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Saltz LB et al. Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy. J. Clin. Oncol. 2007 Oct;25(30):4793-9
Saltz LB et al
2007/01/01
Species: Human, Sample type: Plasma (Not Specified) PubMed
2 Westerweel PE et al. Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur. Heart J. 2008 Nov;29(22):2808-17
Westerweel PE et al
2008/01/01
Sample Type: Serum PubMed
3 Zhu AX et al. Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J. Clin. Oncol. 2009 Jun;27(18):3027-35
Zhu AX et al
2009/01/01
Sample Type: Plasma (EDTA) PubMed
4 Llovet JM et al. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin. Cancer Res. 2012 Apr;18(8):2290-300
Llovet JM et al
2012/01/01
Sample Type: Plasma PubMed
5 Necchi A et al. Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy. Br. J. Cancer 2014 Jan;110(1):26-33
Necchi A et al
2014/01/01
Sample Type: Plasma PubMed
6 Abu El-Asrar AM et al. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res 2013;2013:539658
Abu El-Asrar AM et al
2013/01/01
Sample Type: Vitreous Fluid PubMed
  • No.: 1
  • 文献情報:
    Saltz LB et al. Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy. J. Clin. Oncol. 2007 Oct;25(30):4793-9
    Saltz LB et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Westerweel PE et al. Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur. Heart J. 2008 Nov;29(22):2808-17
    Westerweel PE et al
    2008/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Zhu AX et al. Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J. Clin. Oncol. 2009 Jun;27(18):3027-35
    Zhu AX et al
    2009/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Llovet JM et al. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin. Cancer Res. 2012 Apr;18(8):2290-300
    Llovet JM et al
    2012/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Necchi A et al. Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy. Br. J. Cancer 2014 Jan;110(1):26-33
    Necchi A et al
    2014/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Abu El-Asrar AM et al. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res 2013;2013:539658
    Abu El-Asrar AM et al
    2013/01/01
  • 備考:
    Sample Type: Vitreous Fluid
  • 参照:
    PubMed